Expansion Opportunities Global footprint and multi-country presence (22 countries, 28 locations) combined with a long-standing 60-year track record indicates potential for channel partnerships, distribution expansion, and co-marketing with regional players to penetrate hospitals, laboratories, and biobanking facilities.

Integrated Lab Solutions Portfolio spans preanalytics collection systems, bio-science cell culture and cryopreservation, plus automated biobank storage and microplates. This enables cross-sell of end-to-end lab workflows to existing customers, increasing basket size with bundled offerings.

Digital Health Upsell Greiner eHealth Technologies indicates digital process optimization capabilities. Opportunity to upsell data analytics, digital specimen tracking, and workflow automation to hospitals and labs seeking safety, efficiency, and compliance gains.

Strategic Partnerships Recent partnerships and acquisitions, including science logistics collaboration and SKS365 Malta acquisition, suggest appetite for strategic alliances. Target co-selling with distributors, logistics providers, and biotech firms to broaden market reach and accelerate sales cycles.

Growth Signals Steady product launches (EVOPROTECT and VACUETTE lines) and investments in new tech assets (3D cell culture) signal ongoing innovation. Use as proof points in prospect pitches to hospitals and research institutions prioritizing safety, efficiency, and cutting-edge capabilities.